Learning Module | AccessPharmacy | McGraw Hill Medical

Courses in Therapeutics and Disease State Management | Gastroenterology:

04. Inflammatory Bowel Disease

Content exports do not include quiz or external link content.

AUTHORS:

Monica L. Skomo

LEARNING OBJECTIVES:

Discuss the various etiologies of IBD that have been postulated
Differentiate the major clinical and pathologic features ulcerative colitis and Crohn’s disease, and given these features be able to distinguish between the two
List the common extraintestinal manifestations of IBD
Identify the potential complications of Crohn’s disease and ulcerative colitis
Given a patient’s clinical presentation, assess disease severity for ulcerative colitis and Crohn’s disease
Discuss the therapeutic goals when treating patients with Crohn’s disease and ulcerative colitis
Explain non-pharmacologic therapies used in the management of patients with IBD and their place their place in therapy
Identify the major pharmacologic therapies for ulcerative colitis and Crohn’s disease
Apply the various treatment approaches for IBD as related to disease severity, site of disease, and the need for acute or maintenance therapy
Given an IBD patient history, recommend appropriate pharmacologic and nonpharmacologic therapies and support your recommendation with appropriate rationale
Discuss drug adverse effects and monitoring parameters for drugs and disease states
Construct counseling points for an IBD patient on their disease state and pharmacologic therapy (including proper administration)

External Activity

Lecture and Study Notes on Inflammatory Bowel Disease Supplemental File: Gastroenterology - 04(1). Inflammatory Bowel Disease (Courses in Therapeutics and Disease State Management)(1).pptx

Required

Chapter

AccessPharmacy > Pharmacotherapy: A Pathophysiologic Approach, 10e > Inflammatory Bowel Disease

Required

Access Test (Specific questions)

Inflammatory Bowel Disease Quiz(Passing Score )

Required